- Camryn Hansen | December 03, 2009 8:15 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
Following on the heels of the preemption victory in Wyeth v. Levine, in which the Supreme Court decided that consumers can sue a drug company for inadequate prescription drug labeling...
- Camryn Hansen | September 21, 2009 8:09 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
One woman’s horrific experience with Phenergan, the migraine drug formerly sold by Wyeth, has finally ended in a black box label—the strongest warning offered by the...
- Mike Ferrara | March 05, 2009 8:33 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
In what promises to be one of the most important preemption cases to come out of the Supreme Court this year, Wyeth v. Levine was awarded yesterday by a 6-3 majority to Diana Levine, a Vermont...
- Camryn Hansen | February 28, 2009 11:43 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
Last November, the US Supreme Court heard arguments for Wyeth v. Levine, a crucial preemption case which will decide whether federal law preempts a state law tort action challenging the FDA...
- Camryn Hansen | January 27, 2009 10:39 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
In the largest settlement over inappropriate drug marketing to date, drug giant Pfizer has agreed to pay $2.3 billion to settle a federal investigation into its off-label marketing of the...
- Camryn Hansen | January 19, 2009 10:01 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
Last week, the National Association of Attorneys General (NAAG) issued an Interim Briefing Paper to the President-Elect Barack Obama Transition Team citing the resistance of federal preemption as...
- Mike Ferrara | November 19, 2008 6:22 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
On Monday, the Supreme Court will begin hearing oral arguments in Wyeth v. Levine, which, while deciding whether or not the drug company Wyeth should award damages to plaintiff Diana Levine for...
- Camryn Hansen | November 11, 2008 10:55 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
This week, as the US Supreme Court hears the case of Wyeth v. Levine, centered around the FDA’s continued approval of the Wyeth migraine drug Phenergan for intravenous use via the IV push...
- Mike Ferrara | November 03, 2008 7:08 AM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
This week, the US Supreme Court will begin hearing Wyeth v. Levine, the Court’s third preemption case in less than a year.
At issue in the case is one woman’s horrific experience with...